RxDoctor Payments Data

Chad Scott

Family · Lexington, TNNPI 1134116205

Payments from drug & device makers

$3,001in general payments, 2019–2025

Across 194 payments — averaging $15.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$913
  • AstraZeneca$426
  • AbbVie$395
  • GSK$207
  • Amgen$200
  • Pfizer$189
  • plus $672 from 14 others

What the payments were for

  • Food & beverage$3,001100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,001 in reported general payments places this provider in the 80th percentile of 6,706 family providers in Tennessee.

See all family providers in Tennessee

Most prescribed under Part D

DrugClaimsCost to plans & patients
JanuviaSitagliptin Phosphate55$50,588
FarxigaDapagliflozin Propanediol48$36,538
OzempicSemaglutide30$32,520
EliquisApixaban20$26,591
LinzessLinaclotide31$26,582
Trelegy ElliptaFluticasone/Umeclidin/Vilanter37$23,766
Atorvastatin Calcium329$4,409
Potassium Chloride152$4,315
Lantus SolostarInsulin Glargine,hum.Rec.Anlog33$4,297
BreynaBudesonide/Formoterol Fumarate27$4,144
Colesevelam Hcl21$4,009
Albuterol Sulfate HfaAlbuterol Sulfate227$3,902
Ezetimibe82$3,497
LantusInsulin Glargine,hum.Rec.Anlog19$2,765
Famotidine184$2,628

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
MerckJanuvia$13$50,58855 claims
AstraZenecaFarxiga$426$36,53848 claims
Novo NordiskOzempic$913$32,52030 claims
PfizerEliquis$189$26,59120 claims
AbbVieLinzess$395$26,58231 claims
GSKTrelegy Ellipta$207$23,76637 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 6,706 family providers in Tennessee.

Other family in Lexington

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →